XML 122 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 21 - Disclosures Regarding Fair Value
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]

21.     Disclosures Regarding Fair Value


Assets and Liabilities Measured at Fair Value on a Recurring Basis


The following tables summarize assets and liabilities measured at fair value on a recurring basis at the dates indicated aggregated by the level in the fair value hierarchy within which those measurements fall (in thousands).


   

June 30, 2014

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Assets

                               

Trading account assets

  $ 616     $ 4,765     $ -     $ 5,381  

Investment securities available for sale

                               

U.S. agency

    -       1,946       -       1,946  

State and municipal

    -       5,346       -       5,346  

Collateralized mortgage obligations (federal agencies)

    2,089       88,525       -       90,614  

Other mortgage-backed (federal agencies)

    -       77,332       -       77,332  

SBA loan-backed (federal agency)

    18,289       16,090       -       34,379  

Derivative financial instruments

    -       233       -       233  

Total assets measured at fair value on a recurring basis

  $ 20,994     $ 194,237     $ -     $ 215,231  
                                 

Liabilities

                               

Derivative financial instruments

  $ -     $ 42     $ -     $ 42  

   

December 31, 2013

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Assets

                               

Trading account assets

  $ 1,347     $ 3,771     $ -     $ 5,118  

Investment securities available for sale

                               

State and municipal

    -       7,460       -       7,460  

Collateralized mortgage obligations (federal agencies)

    -       93,132       -       93,132  

Other mortgage-backed (federal agencies)

    1,188       74,832       -       76,020  

SBA loan-backed (federal agency)

    20,457       17,314       -       37,771  

Derivative financial instruments

    -       204       -       204  

Total assets measured at fair value on a recurring basis

  $ 22,992     $ 196,713     $ -     $ 219,705  
                                 

Liabilities

                               

Derivative financial instruments

  $ -     $ 7     $ -     $ 7  

For disclosure regarding the fair value of Pension Plan assets, see Note 16, Benefit Plans.


Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis


For financial assets measured at fair value on a nonrecurring basis that are recorded in the Consolidated Balance Sheets, the following tables summarize the level of valuation assumptions used to determine fair value of the related individual assets at the dates indicated (in thousands). There were no liabilities measured at fair value on a nonrecurring basis at June 30, 2014 or December 31, 2013.


   

June 30, 2014

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Assets

                               

Mortgage loans held for sale

  $ -     $ 4,874     $ -     $ 4,874  

Impaired loans

    558       5,228       -       5,786  

Foreclosed real estate

    23       551       5,861       6,435  

Long-lived assets held for sale

    -       -       685       685  

Total assets measured at fair value on a nonrecurring basis

  $ 581     $ 10,653     $ 6,546     $ 17,780  

   

December 31, 2013

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Assets

                               

Mortgage loans held for sale

  $ -     $ 1,722     $ -     $ 1,722  

Impaired loans

    -       5,588       25       5,613  

Foreclosed real estate

    34       31       6,595       6,660  

Long-lived assets held for sale

    -       -       685       685  

Total assets measured at fair value on a nonrecurring basis

  $ 34     $ 7,341     $ 7,305     $ 14,680  

Level 3 Valuation Methodologies. The following table summarizes the significant unobservable inputs used in the fair value measurements for Level 3 assets measured at fair value on a nonrecurring basis at June 30, 2014 (in thousands).


   

Fair value

 

Valuation technique

 

Significant unobservable inputs

Assets

             

Foreclosed real estate

  $ 5,861  

Appraisals of collateral value

 

Adjustments to appraisal for age of comparable sales

               

Long-lived assets held for sale

    685  

Internal valuation

 

Appraisals and/or sales of comparable properties


Carrying Amounts and Estimated Fair Value of Financial Assets and Liabilities Not Measured at Fair Value


The following table summarizes the carrying amount and fair value of other financial instruments included in the Consolidated Balance Sheets at the dates indicated (in thousands) all of which are considered Level 3 fair value estimates. These fair value estimates are subject to fluctuation based on the amount and timing of expected cash flows as well as the choice of discount rate used in the present value calculation. The Company used management's best estimate of fair value. Thus, the fair values presented may not be the amounts that could be realized in an immediate sale or settlement of the instrument. In addition, any income taxes or other expenses that would be incurred in an actual sale or settlement are not taken into consideration in the fair values presented.


   

Carrying amount

   

Fair value

 

June 30, 2014

               

Financial instruments - assets

               

Loans (1)

  $ 734,481     $ 690,604  
                 

Financial instruments - liabilities

               

Deposits

    928,253       915,282  
                 

December 31, 2013

               

Financial instruments - assets

               

Loans (1)

  $ 748,243     $ 748,330  
                 

Financial instruments - liabilities

               

Deposits

    907,360       896,858  

(1)     Includes gross loans less impaired loans for which fair value exceeds carrying value and allowance for loan losses relative to loans collectively evaluated for impairment.